| |
| |
|
| Insider
Information: |
Meury William |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
65,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,413,750 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
65,000 |
|
|
| Total
Value |
$1,413,750 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 62.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allergan plc |
AGN |
EVP & Chief Commercial... |
2020-05-08 |
0 |
2014-07-01 |
0 |
Premium* |
|
|
Syndax Pharmaceuticals Inc |
SNDX |
|
2024-02-07 |
65,000 |
2021-02-03 |
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGN |
Allergan plc |
See Remarks |
• – – |
2014-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
79,406 |
79,406 |
0 |
- |
|
| AGN |
Allergan plc |
EVP & Pres Branded Pharma |
• – – |
2014-07-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
47,165 |
47,165 |
0 |
- |
|
| AGN |
Allergan plc |
See Remarks |
• – – |
2014-11-26 |
4 |
S |
$269.14 |
$1,224,607 |
D/D |
(4,550) |
81,939 |
0 |
- |
|
| AGN |
Allergan plc |
See Remarks |
• – – |
2014-11-26 |
4 |
OE |
$90.06 |
$637,895 |
D/D |
7,083 |
86,489 |
0 |
- |
|
| AGN |
Allergan plc |
See Remarks |
• – – |
2014-12-05 |
4 |
D |
$266.59 |
$355,098 |
D/D |
(1,332) |
80,607 |
0 |
- |
|
| AGN |
Allergan plc |
See Remarks |
• – – |
2014-12-06 |
4 |
D |
$266.59 |
$658,211 |
D/D |
(2,469) |
78,138 |
0 |
- |
|
| AGN |
Allergan plc |
See Remarks |
• – – |
2014-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
98 |
78,040 |
0 |
- |
|
| AGN |
Allergan plc |
See Remarks |
• – – |
2015-04-01 |
4 |
D |
$296.19 |
$1,669,327 |
D/D |
(5,636) |
72,404 |
0 |
- |
|
| AGN |
Allergan plc |
See Remarks |
• – – |
2015-05-15 |
4 |
D |
$296.60 |
$557,905 |
D/D |
(1,881) |
70,523 |
0 |
- |
|
| AGN |
Allergan plc |
See Remarks |
• – – |
2015-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
423 |
70,100 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Communication Officer |
• – – |
2016-05-15 |
4 |
D |
$223.35 |
$273,157 |
D/D |
(1,223) |
37,059 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Commercial Officer |
• – – |
2016-12-08 |
4 |
D |
$188.47 |
$1,774,257 |
D/D |
(9,414) |
39,452 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Commercial Officer |
• – – |
2016-12-08 |
4 |
OE |
$109.12 |
$1,288,380 |
D/D |
11,807 |
48,866 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Commercial Officer |
• – – |
2017-04-03 |
4 |
A |
$237.68 |
$2,099,903 |
D/D |
8,835 |
48,287 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Commercial Officer |
• – – |
2017-05-15 |
4 |
D |
$228.22 |
$133,965 |
D/D |
(587) |
47,700 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Commercial Officer |
• – – |
2017-10-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,321 |
57,021 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Commercial Officer |
• – – |
2017-12-01 |
4 |
OE |
$78.88 |
$931,336 |
D/D |
11,807 |
68,828 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Commercial Officer |
• – – |
2017-12-01 |
4 |
S |
$173.89 |
$2,053,119 |
D/D |
(11,807) |
57,021 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Commercial Officer |
• – – |
2017-12-29 |
4 |
D |
$163.58 |
$263,527 |
D/D |
(1,611) |
55,410 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Commercial Officer |
• – – |
2018-02-14 |
4 |
OE |
$51.07 |
$1,491,737 |
D/D |
23,613 |
78,600 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Commercial Officer |
• – – |
2018-02-14 |
4 |
S |
$157.18 |
$9,457,369 |
D/D |
(58,879) |
19,721 |
0 |
- |
|
| AGN |
Allergan plc |
Chief Commercial Officer |
• – – |
2018-04-03 |
4 |
D |
$164.74 |
$134,922 |
D/D |
(819) |
18,902 |
0 |
- |
|
| AGN |
Allergan plc |
EVP & Chief Commercial Officer |
• – – |
2018-05-17 |
4 |
OE |
$68.11 |
$1,447,474 |
D/D |
21,252 |
40,154 |
0 |
- |
|
| AGN |
Allergan plc |
EVP & Chief Commercial Officer |
• – – |
2018-05-17 |
4 |
AS |
$154.59 |
$3,775,861 |
D/D |
(24,425) |
15,729 |
0 |
- |
|
| AGN |
Allergan plc |
EVP & Chief Commercial Officer |
• – – |
2018-12-31 |
4 |
D |
$133.66 |
$204,633 |
D/D |
(1,531) |
14,198 |
0 |
- |
|
40 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
